Copyright Reports & Markets. All rights reserved.

Global Opioid Dependence Treatment Market Report, History and Forecast 2017-2028, Breakdown Data by Companies, Key Regions, Types and Application

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview of Opioid Dependence Treatment

    • 1.1 Opioid Dependence Treatment Market Overview
      • 1.1.1 Opioid Dependence Treatment Product Scope
      • 1.1.2 Opioid Dependence Treatment Market Status and Outlook
    • 1.2 Global Opioid Dependence Treatment Market Size Overview by Region 2017 VS 2021 VS 2028
    • 1.3 Global Opioid Dependence Treatment Market Size by Region (2017-2028)
    • 1.4 Global Opioid Dependence Treatment Historic Market Size by Region (2017-2022)
    • 1.5 Global Opioid Dependence Treatment Market Size Forecast by Region (2023-2028)
    • 1.6 Key Regions, Opioid Dependence Treatment Market Size (2017-2028)
      • 1.6.1 North America Opioid Dependence Treatment Market Size (2017-2028)
      • 1.6.2 Europe Opioid Dependence Treatment Market Size (2017-2028)
      • 1.6.3 Asia-Pacific Opioid Dependence Treatment Market Size (2017-2028)
      • 1.6.4 Latin America Opioid Dependence Treatment Market Size (2017-2028)
      • 1.6.5 Middle East & Africa Opioid Dependence Treatment Market Size (2017-2028)

    2 Opioid Dependence Treatment Market Overview by Type

    • 2.1 Global Opioid Dependence Treatment Market Size by Type: 2017 VS 2021 VS 2028
    • 2.2 Global Opioid Dependence Treatment Historic Market Size by Type (2017-2022)
    • 2.3 Global Opioid Dependence Treatment Forecasted Market Size by Type (2023-2028)
    • 2.4 Naloxone
    • 2.5 Buprenorphine
    • 2.6 Methadone

    3 Opioid Dependence Treatment Market Overview by Application

    • 3.1 Global Opioid Dependence Treatment Market Size by Application: 2017 VS 2021 VS 2028
    • 3.2 Global Opioid Dependence Treatment Historic Market Size by Application (2017-2022)
    • 3.3 Global Opioid Dependence Treatment Forecasted Market Size by Application (2023-2028)
    • 3.4 Retail Pharmacies
    • 3.5 Hospitals
    • 3.6 Rehabilitation Centers

    4 Opioid Dependence Treatment Competition Analysis by Players

    • 4.1 Global Opioid Dependence Treatment Market Size by Players (2017-2022)
    • 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Opioid Dependence Treatment as of 2021)
    • 4.3 Date of Key Players Enter into Opioid Dependence Treatment Market
    • 4.4 Global Top Players Opioid Dependence Treatment Headquarters and Area Served
    • 4.5 Key Players Opioid Dependence Treatment Product Solution and Service
    • 4.6 Competitive Status
      • 4.6.1 Opioid Dependence Treatment Market Concentration Rate
      • 4.6.2 Mergers & Acquisitions, Expansion Plans

    5 Company (Top Players) Profiles and Key Data

    • 5.1 Reckitt Benckiser Pharmaceuticals
      • 5.1.1 Reckitt Benckiser Pharmaceuticals Profile
      • 5.1.2 Reckitt Benckiser Pharmaceuticals Main Business
      • 5.1.3 Reckitt Benckiser Pharmaceuticals Opioid Dependence Treatment Products, Services and Solutions
      • 5.1.4 Reckitt Benckiser Pharmaceuticals Opioid Dependence Treatment Revenue (US$ Million) & (2017-2022)
      • 5.1.5 Reckitt Benckiser Pharmaceuticals Recent Developments
    • 5.2 Mylan
      • 5.2.1 Mylan Profile
      • 5.2.2 Mylan Main Business
      • 5.2.3 Mylan Opioid Dependence Treatment Products, Services and Solutions
      • 5.2.4 Mylan Opioid Dependence Treatment Revenue (US$ Million) & (2017-2022)
      • 5.2.5 Mylan Recent Developments
    • 5.3 Dr. Reddy's Laboratories
      • 5.3.1 Dr. Reddy's Laboratories Profile
      • 5.3.2 Dr. Reddy's Laboratories Main Business
      • 5.3.3 Dr. Reddy's Laboratories Opioid Dependence Treatment Products, Services and Solutions
      • 5.3.4 Dr. Reddy's Laboratories Opioid Dependence Treatment Revenue (US$ Million) & (2017-2022)
      • 5.3.5 ADAPT Pharma Recent Developments
    • 5.4 ADAPT Pharma
      • 5.4.1 ADAPT Pharma Profile
      • 5.4.2 ADAPT Pharma Main Business
      • 5.4.3 ADAPT Pharma Opioid Dependence Treatment Products, Services and Solutions
      • 5.4.4 ADAPT Pharma Opioid Dependence Treatment Revenue (US$ Million) & (2017-2022)
      • 5.4.5 ADAPT Pharma Recent Developments
    • 5.5 LUMITOS AG
      • 5.5.1 LUMITOS AG Profile
      • 5.5.2 LUMITOS AG Main Business
      • 5.5.3 LUMITOS AG Opioid Dependence Treatment Products, Services and Solutions
      • 5.5.4 LUMITOS AG Opioid Dependence Treatment Revenue (US$ Million) & (2017-2022)
      • 5.5.5 LUMITOS AG Recent Developments

    6 North America

    • 6.1 North America Opioid Dependence Treatment Market Size by Country (2017-2028)
    • 6.2 United States
    • 6.3 Canada

    7 Europe

    • 7.1 Europe Opioid Dependence Treatment Market Size by Country (2017-2028)
    • 7.2 Germany
    • 7.3 France
    • 7.4 U.K.
    • 7.5 Italy
    • 7.6 Russia

    8 Asia-Pacific

    • 8.1 Asia-Pacific Opioid Dependence Treatment Market Size by Region (2017-2028)
    • 8.2 China
    • 8.3 Japan
    • 8.4 South Korea
    • 8.5 India
    • 8.6 Australia
    • 8.7 Taiwan
    • 8.8 Indonesia

    9 Latin America

    • 9.1 Latin America Opioid Dependence Treatment Market Size by Country (2017-2028)
    • 9.2 Mexico
    • 9.3 Brazil
    • 9.4 Argentina

    10 Middle East & Africa

    • 10.1 Middle East & Africa Opioid Dependence Treatment Market Size by Country (2017-2028)
    • 10.2 Turkey
    • 10.3 Saudi Arabia
    • 10.4 UAE

    11 Opioid Dependence Treatment Market Dynamics

    • 11.1 Opioid Dependence Treatment Industry Trends
    • 11.2 Opioid Dependence Treatment Market Drivers
    • 11.3 Opioid Dependence Treatment Market Challenges
    • 11.4 Opioid Dependence Treatment Market Restraints

    12 Research Finding /Conclusion

      13 Methodology and Data Source

      • 13.1 Methodology/Research Approach
        • 13.1.1 Research Programs/Design
        • 13.1.2 Market Size Estimation
        • 13.1.3 Market Breakdown and Data Triangulation
      • 13.2 Data Source
        • 13.2.1 Secondary Sources
        • 13.2.2 Primary Sources
      • 13.3 Disclaimer

      Summary:
      Market Insights
      The research report studies the Opioid Dependence Treatment market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
      Due to the COVID-19 pandemic, the global Opioid Dependence Treatment market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.
      The global main companies of Opioid Dependence Treatment include Reckitt Benckiser Pharmaceuticals, Mylan, Dr. Reddy's Laboratories, ADAPT Pharma and LUMITOS AG, etc. In 2021, the global six largest players have a share approximately % in terms of revenue.
      The North America Opioid Dependence Treatment market is estimated at US$ million in 2021, while China is forecast to reach US$ million by 2028. The proportion of the China is % in 2021 and it is predicted that the share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Opioid Dependence Treatment landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
      Naloxone accounting for % of the Opioid Dependence Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Retail Pharmacies segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
      Segment Scope
      An intensive study of key type and application segments has been done in this segmentation section. The authors of the report have provided reliable figures including revenue forecast data by type and application for the period 2017-2028. They have also studied how the segments are gaining or losing growth in various geographies and their respective countries. Thanks to this study, readers can thoroughly grasp the growth pattern and potential of different segments.
      Segment by Type
      Naloxone
      Buprenorphine
      Methadone
      Segment by Application
      Retail Pharmacies
      Hospitals
      Rehabilitation Centers
      Regional Scope
      This segment of the report offers a thorough regional study of the global Opioid Dependence Treatment market. Drivers and restraints for each region are broadly examined in the report. Readers will get familiar with the driving forces and challenges that are specific to the regions. The specialists have identified growth opportunities in key geographical regions and their respective countries to aid players to reinforce their presence. All the regions and their countries in the report are assessed based on the growth rate and revenue according to the consumption for the period 2017-2028. This geographical analysis will help readers to gain in-depth knowledge of the regional growth. The key geographical regions surveyed in this research report involve North America, Europe, Asia Pacific, Central and South America, and Middle East and Africa. The report has specifically covered major countries including United States, Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
      Key Players
      This section has provided an exhaustive analysis of the strategies that the companies are focusing on to stay ahead of other players. The strategies mainly involve research and development, new product developments, and mergers and acquisitions. The researchers have also provided revenue shares of the key companies, company overview, and the latest company developments so as to help players to sustain the cutthroat competition. In this section, the report offers global revenue data of manufacturers for the period 2017-2022. Following is the list of key manufacturers observed in this research study:
      Reckitt Benckiser Pharmaceuticals
      Mylan
      Dr. Reddy's Laboratories
      ADAPT Pharma
      LUMITOS AG
      Frequently Asked Questions
      Which application segment captured the leading share in the Opioid Dependence Treatment market?
      How fragmented is the Opioid Dependence Treatment market?
      Which are the key growth drivers in the Opioid Dependence Treatment market?
      Which are the top strategies undertaken by the Opioid Dependence Treatment market players?
      Which technological trends are likely to affect the Opioid Dependence Treatment market?
      What is the expected Opioid Dependence Treatment market size by 2028?
      Which companies are dominating the Opioid Dependence Treatment market?
      Which region is projected to witness the fastest growth in the future?
      What factors are restraining the Opioid Dependence Treatment market growth?
      Which are the emerging companies in the Opioid Dependence Treatment market?
      Buy now